FDA approves Dupixent (dupilumab) as treatment for chronic rhinosinusitis

Chronic rhinosinusitis (CRS) is a clinical condition characterized by prolonged inflammation (more than 12 weeks) of the nose and paranasal sinuses. Signs and symptoms of sinusitis include headache, swelling of face, facial pain, nasal discharge, dizziness, and breathing difficulties. Sinusitis is caused by allergies, bacterial and viral infections and presence of nasal polyps (growths on […]

NICE guidelines for Cochlear implantation in children and adults

According to the definition by American Academy of Family Physicians, Clinical practice guidelines are statements that include recommendations intended to optimize patient care. The National Institute for Health and Care Excellence (NICE) is a non-departmental public body in England, that provides national guidance and advice to improve health and social care. On 7th March 2019, […]

World Hearing Day

Globally it is estimated that over 5% of the world’s population i.e around 466 million people – have disabling hearing loss (432 million adults and 34 million children). Unaddressed hearing loss is the leading cause of morbidity and poses an annual cost of $750 billion globally. It is estimated that by 2050 over 900 million […]

WHO launches “hearWHO” app for mobile devices to help detect hearing loss

To mark the World Hearing Day, the World Health Organization (WHO) has launched “hearWHO“, a free application for smart mobile devices which allows people to check their hearing regularly and intervene early in case of hearing loss. Over 5% of the world’s population i.e around 466 million people – have disabling hearing loss (432 million […]

Cell phone radiofrequency could enhance head and neck cancers – New study says

Developments in wireless communication technology over the last twenty years resulted in increasingly widespread use of mobile phones and wireless systems for communication purposes. This has led to concerns regarding potential adverse health effects, particularly of the central nervous system, of which the brain is the part most exposed to the radio frequency electromagnetic fields […]

Prestin and Otolin 1 – early biomarkers of Noise Induced Hearing Loss (NIHL)

Noise induced hearing loss (NIHL) is defined as reduction in auditory acuity (hearing ability) associated with long term exposure to loud sounds. It is the second most common form of sensorineural hearing deficit, after presbycusis (age-related hearing loss). There can be two types of hearing loss due to exposure to loud sounds. The first one is temporary […]

Replacement of trachea with aortic grafts – a novel treatment for tracheal stenosis

Replacement of trachea after extensive resection still remains as a major challenge for the thoracic surgeons even after decades of intensive research. End to end anastomosis is difficult or almost not possible, when more than 5-6 cm of trachea is resected out. Several clinical solutions with skin, esophagus and bowel etc. have been proposed to tackle […]

CLiKX – A novel device for treatment of Otitis Media with Effusion in Children

Otitis Media with Effusion (OME), also known as Glue ear, Secretory Otitis Media or Serous Otitis Media is a clinical condition characterized by collection of non-infected fluid in the middle ear space as a result of a cold, sore throat or upper respiratory infection. This is a highly common pediatric disease (can affect adults also) […]

Role of Balloon dilatation in chronic rhinosinusitis – Clinical consensus statement 2018

Chronic rhinosinusitis (CRS) is a clinical condition characterised by inflammation of the paranasal sinuses that typically lasts beyond twelve weeks. It is caused by infections, allergies, and the presence of sinus polyps or deviated septum. Signs and symptoms include headache, nasal discharge, swelling in the face, dizziness, and breathing difficulties. The condition is so common […]

What’s new in AJCC 8th Edition, Head and Neck section?

The recently released 8th edition of the AJCC TNM Cancer Staging Manual, Head and Neck Section incorporates significant changes based on advances in our understanding of the etiology and certain histologic attributes of tumors. The most significant update in AJCC 8th edition, is the creation of a separate staging algorithm for high risk human papillomavirus associated […]